S-Biomedic develops Living Skin Probiotics derived from Cutibacterium to restore balance in the skin microbiome, addressing conditions such as acne, eczema, and rosacea. Their technology enables the recovery of a healthy microbiome community, promoting skin health and resilience.
Funding
Funding not disclosed
Founders
Product
Problem
Imbalances in the skin microbiome are associated with various skin conditions, including acne, eczema, and rosacea. Current skincare solutions often fail to address the root cause of these issues: the disruption of the skin's natural microbial ecosystem. This can lead to ineffective treatments and recurring skin problems.
Solution
S-Biomedic develops Living Skin Probiotics derived from Cutibacterium, a major skin microbe, to restore balance in the skin microbiome. These probiotics can live on the skin, enabling the recovery of a healthy microbiome community. By modulating the population of skin bacteria, S-Biomedic's technology helps the skin return to its natural and healthy state, addressing the underlying causes of acne and other skin disorders. Their Sencyr® program leverages this technology to modulate and reset acne-prone skin.
Target Audience
The primary target audience includes individuals suffering from skin conditions like acne, eczema, and rosacea, as well as scientists, researchers, manufacturers, brands, and investors in the skincare industry.
Features
- Living Skin Probiotics derived from Cutibacterium
- Targets the skin microbiome to address skin conditions
- Enables the recovery of a healthy microbiome community
- Sencyr® microbiome care program for acne-prone skin